Generic Name and Formulations:
Pseudoephedrine HCl 30mg; tabs; with meth-deterring Impede technology.
Acura Pharmaceuticals, Inc.
Indications for NEXAFED:
Nasal or sinus congestion.
Swallow whole with water. 60mg every 4–6 hrs; max 4 doses/24hrs.
<6yrs: do not use without consultation. Swallow whole with water. 6–11yrs: 30mg every 4–6 hrs; max 4 doses/24hrs.
During or within 14 days of MAOIs.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Reevaluate if no improvements after 7 days. Pregnancy. Nursing mothers.
Hypertensive crisis with MAOIs. β-blockers increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Nervousness, dizziness, insomnia.
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Smartphone App Helps Evaluate Catastrophizing in Chronic Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Dozens of Medical Groups Join Forces to Improve Diagnoses
- FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track Status
- Little to No Association Found Between Physician Performance and Medical School Ranking